Theriva Biologics, Inc. (TOVX) Ownership

$0.23

$0.01 (-3.68%)
Last update: 01:07 PM EST
Day's range
$0.21
Day's range
$0.25

Theriva Biologics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MSD PARTNERS, L.P. 08/14/2024 598.41 K $141.41 K   100.00% 3.49%
VANGUARD GROUP INC 08/13/2024 194.49 K $45.96 K   -13.66% 1.13%
BLACKROCK INC. 08/13/2024 189.18 K $44.70 K   0.00% 1.10%
GEODE CAPITAL MANAGEMENT, LLC 08/09/2024 141.17 K $33.37 K   0.00% 0.82%
RENAISSANCE TECHNOLOGIES LLC 08/09/2024 103.71 K $24.51 K   51.38% 0.60%
TWO SIGMA SECURITIES, LLC 08/14/2024 61.02 K $14.42 K   186.86% 0.36%
STATE STREET CORP 08/14/2024 48.69 K $11.51 K   0.00% 0.28%
NORTHERN TRUST CORP 08/14/2024 26.48 K $6.26 K   -0.46% 0.15%
ADVISOR GROUP HOLDINGS, INC. 08/13/2024 11.05 K $2.61 K   23,404.26% 0.06%
SAGEVIEW ADVISORY GROUP, LLC 08/12/2024 10.43 K $1.00 M   0.00% 0.06%
BLAIR WILLIAM & CO/IL 08/12/2024 10.15 K $2.40 K   0.00% 0.06%
FMR LLC 08/13/2024 500 $118   4,900.00% 0.00%
IRON HORSE WEALTH MANAGEMENT, LLC 07/22/2024 365 $86   0.00% 0.00%
IFP ADVISORS, INC 07/30/2024 296 $70   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 08/14/2024 146 $34   2,333.33% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/13/2024 145 $34   0.00% 0.00%
PLANNING CAPITAL MANAGEMENT CORP 08/12/2024 110 $26   100.00% 0.00%
WELLS FARGO & COMPANY/MN 08/13/2024 100 $24   -57.08% 0.00%
OLD POINT TRUST & FINANCIAL SERVICES N A 08/13/2024 100 $24   0.00% 0.00%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 08/08/2024 14 $3   0.00% 0.00%
UBS GROUP AG 08/14/2024 3 $1   0.00% 0.00%
LINCOLN NATIONAL CORP 07/25/2024 0 $0   -100.00% 0.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2024 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 08/14/2024 0 $0   -100.00% 0.00%

Theriva Biologics, Inc. institutional Ownership - FAQ's

During the previous two years, 2 institutional investors and hedge funds held shares of Theriva Biologics, Inc.. The most heavily invested institutionals were:

Planning Capital Management Corp: 0

BlackRock Inc.: 189,181

8.14% of Theriva Biologics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 189.18 K shares in the last 24 months. This purchase volume represents approximately $43.51 K in transactions.